JCAD | The Journal of Clinical and Aesthetic Dermatology (JCAD)

JCAD | The Journal of Clinical and Aesthetic Dermatology

   

JCAD » 2010 » November

Archives

Sponsors

<img src="http://www.jcadonline.com/ad-content/cloderm/banner_noflash.png" >

The Impact of the Current United States Guidelines on the Management of Actinic Keratosis: Is It Time for an Update?

November 2010

George Martin, MD
Dermatology and Laser Center of Maui, Kihei, Hawaii Read the rest of this article »

Posted in 11-2010 (November 2010), Actinic Keratoses, Actinic Keratosis, Literature Review | No Comments »

A Review of the Safety and Efficacy of Benzoyl Peroxide (5.3%) Emollient Foam in the Management of Truncal Acne Vulgaris

November 2010

Joseph Bikowski, MD
Clinical Assistant Professor, Department of Dermatology, Ohio State University, Columbus, Ohio; Bikowski Skin Care Center at Sewickley Station, Sewickley, Pennsylvania

Dr. Bikowski discloses the following: Allergan—speakers’ bureau, honoraria; Coria—advisory board, consultant, honoraria, speakers’ bureau; Galderma—advisory board, consultant, honoraria, speakers’ bureau; OrthoNeutrogena—advisory board, consultant, honoraria, speakers’ bureau; Stiefel, a GSK Company—advisory board, consultant, honoraria, speakers’ bureau. Read the rest of this article »

Posted in 11-2010 (November 2010), Acne, Benzoyl Peroxide, Literature Review | No Comments »

Prospective Demographic Study of Cosmetic Surgery Patients

November 2010

Joel Schlessinger, MD, FAAD, FAACS; Daniel Schlessinger; Bernard Schlessinger, PhD
Advanced Skin Research Center, Omaha, Nebraska

Disclosure: Dr. Joel Schlessinger is a researcher for Medicis, Allergan, Merz, and Mentor. Daniel Schlessinger and Dr. Bernard Schlessinger report no relevant conflicts of interest. Read the rest of this article »

Posted in 11-2010 (November 2010), Cosmetic Surgery, Original Research | 3 Comments »

Peroxide as a Novel Treatment for Ecchymoses

November 2010

Matthew A. Molenda, MD, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio; Novie Sroa, MD, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio; Shannon M. Campbell, DO, Division of Dermatology, Ohio University O’Bleness Hospital; Athens, Ohio; Mark A. Bechtel, MD, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio; E. Mitch Opremcak, MD, Department of Ophthalmology, The Ohio State University Medical Center, Columbus, Ohio

Disclosure: Drs. Molenda, Sroa, Campbell, and Bechtel have no relevant conflicts of interest. Dr. Opremcak has filed a patent (PCT/US2005/040993) for this method of treating ecchymoses.

Abstract
Ecchymoses, commonly known as bruises, frequently occur after injury to the skin causes extravasation of red blood cells into interstitial tissue. This extravasation can lead to an inflammatory cascade. The case report presented details one patient who displayed rapid improvement in the pain and appearance of a partially treated bruise on her thigh after an eight-hour application of hydrogen peroxide 15% carbamide gel under occlusion. Hydrogen peroxide 15% carbamide gel may represent a novel treatment for ecchymoses. This potential new treatment for bruises needs to be studied further to detail its adverse effects, safety profile, and efficacy profile.  (J Clin Aesthet Dermatol. 2010;3(11):36–38.)

Read the rest of this article »

Posted in 11-2010 (November 2010), Case Report | No Comments »

An Evaluation of Evidence Regarding Application of Silicone Gel Sheeting for the Management of Hypertrophic Scars and Keloids

November 2010

Morgan McCarty, DO; James Q. Del Rosso, DO, FAOCD

Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Dr. McCarty is from Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Dr. Del Rosso is a consultant, speaker, and or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott. Dr. McCarty reports no relevant conflicts of interest. Read the rest of this article »

Posted in 11-2010 (November 2010), Questions-Challenges-Controversies | No Comments »

Application of Nutrigenomics in Skin Health: Nutraceutical or Cosmeceutical?

November 2010

M.T. Ravi Subbiah, PhD

Dr. Subbiah is from the Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio. Disclosure: Dr. Subbiah reports no relevant conflicts of interest.

Abstract
Nutrigenomics is a growing field related to genetic testing based on the documentation of genetic mutations in an individual, giving us the ability to correct metabolic imbalances (personalized medicine) through specific dietary supplements or nutraceuticals. An off-shoot of nutrigenomics called dermagenetics (testing for selected genetic mutations related to skin health followed by advocating the use of either nutraceuticals or skin creams enriched by cosmeceuticals) is heading toward commercialization at a rapid rate by directly targeting the public. Although this growth represents an opportunity to explore the benefits of genetic advances in skin health, it is essential that the science, product claims, and ethical standards be critically evaluated and clear national guidelines be set in order to protect the consumer. Read the rest of this article »

Posted in 11-2010 (November 2010), Commentary, Cosmeceuticals, Nutraceutical, Nutrigenomics | No Comments »